戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (right1)

通し番号をクリックするとPubMedの該当ページを表示します
1 otein 1) and enhanced cap-independent Cd40 mRNA translation as assessed by a bicistronic reporter that contained the 5'-U
2 EE), plasma metabolites, and glucose and insulin metabolism as assessed by a frequently sampled intravenous glucose toler
3  (SCCS) to examine the association between coffee drinking, as assessed by a semi-quantitative food frequency questionnai
4 ting of language in either the left and/or right hemisphere as assessed by a very high incidence of dissociations across
5 s with an objective response (complete or partial response) as assessed by an independent radiologic review committee acc
6 addition the MLNPs also induced higher levels of apoptosis, as assessed by annexin V/PI assays and increased caspase 3/7
7  the effect of the knowledge of presence of atherosclerosis as assessed by bilateral carotid/femoral vascular ultrasound.
8 hows close correspondence with the extent of tau pathology, as assessed by Braak tangle stage.
9      Attainment and maintenance of a stable ocular surface, as assessed by change in the ocular surface severity scores w
10 r cells to ionizing radiation (IR) and etoposide treatment, as assessed by clonogenic survival and short-term proliferati
11 cryoballoon ablation than with antiarrhythmic drug therapy, as assessed by continuous cardiac rhythm monitoring.
12 ee population modes of brain covariation, which were robust as assessed by cross-validation and permutation testing, taki
13 overy of free GMT upon hydrolysis, with biological activity as assessed by cytotoxicity assays performed in adenocarcinom
14 g strength of association between an event and a test item, as assessed by different false-memory paradigms.
15  donors for maturation of the mitochondrial apo-aconitase 2 as assessed by enzyme activity measurements.
16 condary structural elements conveying high affinity to DUX4 as assessed by fluorescence resonance energy transfer and flu
17 tor, talazoparib led to increased DNA double strand breaks, as assessed by gamma-H2AX foci formation, as compared to LuTa
18 ecrease in hepatic B lymphocytes compared to untreated mice as assessed by high-definition mass cytometry by time-of-flig
19   TSP-1(-/-) mice administered AOM had reduced liver injury as assessed by histology and serum transaminase levels compar
20 en expression of IRS-1 in L1CAM(+) exosomes and systemic IR as assessed by homeostatic model assessment of IR in HC, but
21 CDCP1 and PKCdelta (CDCP1_ pY743(+) and PKCdelta_pY311(+)), as assessed by immunohistochemistry, indicating increased SFK
22 harmacologic inflammasome stimulation increased HSPC number as assessed by in situ hybridization for runx1/cmyb and flow
23 microvessels, resulting in improved microvascular function, as assessed by laser Doppler imaging and iontophoresis of ace
24                 The primary endpoint was objective response as assessed by local investigators in an intention-to-treat a
25 icantly attenuated P. aeruginosa-induced acute lung injury, as assessed by lung wet-to-dry weight ratio, BAL protein leve
26  improved long-term motor behavior, reduced edema formation as assessed by magnetic resonance imaging, and reduced lesion
27 suggests that a 30% relative reduction in liver fat content as assessed by magnetic resonance imaging-proton density fat
28 rate than published and/or NOVOPlasty-reassembled plastomes as assessed by mapping.
29 the exosomes, is mainly responsible for exo-HAV infectivity as assessed by methylene blue inactivation of non-encapsidate
30 it immediately preceding ECC diagnosis with an AUC of 0.89, as assessed by nested cross-validation.
31   These cells had increased activation of the mTOR pathway, as assessed by phosphorylated ribosomal protein S6 expression
32 ingle underlying construct explaining most of the variance, as assessed by Principal Component Analysis, which we interpr
33 ity-associated adipose tissue inflammation and dysfunction, as assessed by proinflammatory macrophage accumulation.
34  well as nonischemic-challenged steatotic livers (P < 0.05) as assessed by RCM.
35 expression increased in livers of older patients with NASH, as assessed by real time quantitative PCR (RT-qPCR) or wester
36 of the following outcomes: radiological objective response (as assessed by Response Evaluation Criteria in Solid Tumors 1
37   Significant improvement of motor function and disability (as assessed by the Burke Fahn Marsden's Dystonia Rating Scale
38 anisms of psychomotor sensitization and drug reinforcement, as assessed by the conditioned place preference and drug self
39 nts with an overall response (complete or partial response) as assessed by the investigators according to RECIST 1.1.
40 tcome was odds of fibrosis progression by one or more stage as assessed by the Nonalcoholic Steatohepatitis Clinical Rese
41 e impact of ADAs on ustekinumab level and clinical response as assessed by the PASI.
42 re inversely correlated with degree of respiratory failure, as assessed by the ratio of Pao(2) to fraction of inspired ox
43 dpoint was all-cause mortality, or discharge from hospital, as assessed by the reporting sites during the patient hospita
44    The primary outcome was fibroid-related quality of life, as assessed by the score on the health-related quality-of-lif
45      Unlike absolute hyperglycemia, relative hyperglycemia, as assessed by the stress hyperglycemia ratio, independently
46 31) or did not meet (n = 73) criteria for insomnia disorder as assessed by the Structured Clinical Interview for DSM-5 co
47 p of 18.9 months (IQR 10.4-23.8), progression-free survival as assessed by the study investigator was significantly prolo
48                                                             As assessed by time-of-flight mass cytometry, total macrophag
49                Assay precision varied between laboratories, as assessed by variance in control measurements (from 0.1 to
50               Prevalence of global acute malnutrition (GAM) as assessed by weight for height in R2 (12.1%, 95% CI: 9.6-15